Drug products: Bensylpenicillin® Meda, BENZETACIL 1.200.000, Benzylpenicillin Panpharma, Bicillin C-R 900/300, Lentocilin S 1200, Pendysin, PFIZERPEN, Tardocillin, Tardocillin 1200
ATC code: J01CE01, J01CE08, J01CR50
Substances: benzylpenicillin, benzylpenicillin potassium, benzylpenicillin sodium, benzylpenicillin, procaine
Controlled studies on differences between men and women regarding safety and pharmacokinetics of benzylpenicillin are lacking. A cohort study has shown an higher serological cure of syphilis in men than in women following treatment with benzylpenicillin.
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of benzylpenicillin have been found.
A register-based cohort study including 1327 patients with syphilis (782 men, 545 women) showed higher serological cure in men than in women, following treatment with benzylpenicillin .
No studies with a clinically relevant sex analysis regarding adverse effects of benzylpenicillin have been found.
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Date of litterature search: 2021-01-11
Reviewed by: Diana Rydberg
Approved by: Karin Schenck-Gustafsson